Search results
Moderna’s flu-COVID combo shot hits goal in late-stage trial - The Boston Globe
The Boston Globe· 6 days agoModerna’s combination shot generated higher immune responses against the influenza virus and SARS-...
Moderna’s flu-COVID combo shot hits goal in late-stage trial
Detroit News· 6 days agoModerna’s combination shot generated higher immune responses against the influenza virus and SARS-...
Combo COVID/flu vaccine elicits higher immune response in trial
United Press International via Yahoo News· 6 days agoAn experimental vaccine that could offer one-stop prevention for both COVID-19 and influenza is...
FDA recommends COVID jab manufacturers update formulas to combat new strain
BizPac Review· 1 day agoThe U.S. Food and Drug Administration (FDA) announced Thursday that manufacturers of the COVID vaccines should focus on the KP.2 strain of the JN.1 variant ...
Past COVID infections may help protect against certain colds. Could it lead to better vaccines?
Medical Xpress· 4 days agoA new study suggests previous COVID-19 infections lower the risk of getting colds caused by milder...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
AOL· 6 days agoA combination COVID-influenza vaccine is apparently one step closer to hitting the market. Moderna, which is developing the experimental vaccine, announced ...
Here are 7 things Arizonans need to know about the new KP.3 variant of COVID-19
AZCentral | The Arizona Republic via Yahoo News· 4 days agoHe said he'd be surprised if there is a "noticeable" increase in illness due to KP.3 during the next few months. New COVID-19 vaccines anticipated for fall should provide ...
Here are 7 things Arizonans need to know about the new KP.3 variant of COVID-19
The Arizona Republic· 4 days agoA new variant of COVID-19 called KP.3 is on the rise in the U.S. and has been detected in Arizona....
FDA reverses course, calls for vaccines for fall 2024 to target newer COVID-19 strain
Scripps News via AOL· 2 days agoThe FDA is reversing course on its COVID vaccine guidance: Rather than having a vaccine that targets...
US government to fund up to $500 million for studies on oral, nasal COVID vaccines
Reuters via Yahoo News· 3 days agoThe funding is part of Project NextGen, a $5 billion initiative led by the Biomedical Advanced Research and Development Authority (BARDA), to advance a pipeline of new, innovative vaccines ...